-Advertisement-
-Advertisement-
Metabolic
Oral Treatment for Acromegaly Shows Promise
An investigational oral form of octreotide may be beneficial in patients with acromegaly as a maintenance treatment, according to results of the Chiasma OPTIMAL study reported at ENDO 2020, the Endocrine Society's annual meeting. In the phase 3 randomized controlled clinical trial, 56 adults with active acromegaly were randomly assigned...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
Videos
01 Mar, 2020
-Advertisement-
Contact
© 2024 Med Journal 360™ is a trademark of International Healthcare Media, LLC. All rights Reserved